Patent · US Active

5-hydroxytryptamine receptor 7 activity modulators and their method of use

US11897870B2 · kind B2 · utility

1Cited by

6References

7Claims

0Family size

Assignee

Temple University-Of The Commonwealth System of Higher Education · US

Inventors

Daniel J. Canney · Ambler, US
Benjamin E. Blass · Eagleville, US
Rong Gao · Eugene, US
Magid A. Abou-Gharbia · Wilmington, US

Key dates

Filing date	Apr 28, 2020
Grant date	Feb 13, 2024
Priority date	—
Expiry date	May 8, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.